Abstract
Botulinum toxin therapy has been a life-changing treatment for patients with facial dystonias. The following articles describe an initial experience with as well as a long-term follow-up of botulinum toxin treatment for these conditions with excellent early and long-term results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schantz EJ, Johnson EA (1997) Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med 40:317–327
Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044–1049
Frueh BR, Felt DP, Wojno THMD (1984) Treatment of blepharospasm with botulinum toxin. Arch Ophthalmol 102:1464
Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103:347–350
Czyz CN, Burns JA, Petrie TP, Watkins JR, Cahill KV, Foster JA (2013) Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome. Am J Ophthalmol 156:173–177.e2
Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel’s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 39:1204–1209
Anderson RL, Patel BCK, Holds JB, Jordan DR (1998) Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg 14:305–317
Carruthers JDA, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17–21
Maasumi K, Thompson NR, Kriegler JS, Tepper SJ (2015) Effect of onabotulinumtoxinA injection on depression in chronic migraine. Headache 55:1218–1224
Stearns TP, Shad MU, Guzman GC (2018) Glabellar botulinum toxin injections in major depressive disorder. Prim Care Companion CNS Disord 20:1–8
Zamanian A, Ghanbari Jolfaei A, Mehran G, Azizian Z (2017) Efficacy of botox versus placebo for treatment of patients with major depression. Iran J Public Health 46:982–984
Dressler D, Karapantzou C, Rohrbach S, Schneider S, Laskawi R (2017) Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results. J Neural Transm 124:253–257
Brandt F, Swanson N, Baumann L, Huber B (2009) Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatologic Surg 35:1893–1901
Steinsapir KD, Rootman D, Wulc A, Hwang C (2015) Cosmetic microdroplet botulinum toxin A forehead lift. Ophthal Plast Reconstr Surg 31:263–268
Evinger C (2015) Benign essential blepharospasm is a disorder of neuroplasticity: lessons from animal models. J Neuroophthalmol 35:374–379
Namiguchi K, Mizoue S, Ohta K, Shiraishi A (2018) Effect of botulinum toxin A treatment on eyelid pressure in eyes with blepharospasm. Curr Eye Res 43:896–901
Gil Polo C, RodrÃguez Sanz MF, Berrocal Izquierdo N, Castrillo Sanz A, Gutiérrez RÃos R, Zamora GarcÃa MI, Mendoza RodrÃguez A, Duarte GarcÃa-Luis J (2013) Blefarospasmo y espasmo hemifacial: tratamiento a largo plazo con toxina botulÃnica. Neurologia 28:131–136
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ramesh, S. (2022). Treatment of Blepharospasm with Botulinum Toxin. In: Foundational Papers in Oculoplastics . Springer, Cham. https://doi.org/10.1007/978-3-030-92794-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-92794-3_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-92793-6
Online ISBN: 978-3-030-92794-3
eBook Packages: MedicineMedicine (R0)